|
市場調査レポート
商品コード
1450072
ワクチンの世界市場 2024-2028Global Vaccines Market 2024-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
ワクチンの世界市場 2024-2028 |
出版日: 2024年03月05日
発行: TechNavio
ページ情報: 英文 163 Pages
納期: 即納可能
|
ワクチン市場は2023-2028年に563億9,000万米ドル、予測期間中のCAGRは13.83%で成長すると予測されます。
当レポートでは、ワクチン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ワクチン開発および新規ワクチン発売のための資金調達の増加、慢性感染症に対する新規ワクチンのニーズ、ワクチンにおけるアジュバントの使用の増加によって牽引されています。
市場範囲 | |
---|---|
基準年 | 2024 |
終了年 | 2028 |
予測期間 | 2024-2028 |
成長モメンタム | 加速 |
前年比2024年 | 12.85% |
CAGR | 13.83% |
増分額 | 563億9,000万米ドル |
本調査では、ナノ粒子ワクチンの市場開拓が、今後数年間のワクチン市場成長を牽引する主要な理由の1つであるとしています。また、旅行者の間でワクチンで予防可能な病気に対する認識が高まり、ワクチン送達システムが進歩することで、同市場では大きな需要が見込まれます。
Exhibits:
The vaccines market is forecasted to grow by USD 56.39 bn during 2023-2028, accelerating at a CAGR of 13.83% during the forecast period. The report on the vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased funding for vaccine development and new vaccine launches, need for novel vaccines for chronic infections, and increasing use of adjuvants in vaccines.
Technavio's vaccines market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 12.85% |
CAGR | 13.83% |
Incremental Value | $56.39bn |
By Type
By End-user
By Geographical Landscape
This study identifies the development of nanoparticle vaccines as one of the prime reasons driving the vaccines market growth during the next few years. Also, increase in awareness of vaccine-preventable diseases among travelers and advancement in vaccine delivery system will lead to sizable demand in the market.
The report on the vaccines market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccines market vendors that include Astellas Pharma Inc., Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novavax Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., Valneva SE, and AstraZeneca PLC. Also, the vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.